IGF2BP3 and metabolic dysfunction-associated steatohepatitis: In vivo, IGF2BP3 cKO mice exhibited higher levels of FPT indicators, such as iron, MDA, ROS, and depleted GSH, compared to NASH or CCl4 model control mice.